Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,376,741 papers from all fields of science
Search
Sign In
Create Free Account
Waardenburg Syndrome
Known as:
syndrome waardenburg
, Syndrome, Waardenburg's
, Syndrome, Waardenburg
Expand
Rare, autosomal dominant disease with variable penetrance and several known clinical types. Characteristics may include depigmentation of the hair…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
26 relations
Narrower (11)
ABCD syndrome
Van der Hoeve Halbertsma Waardenburg Gualdi Syndrome
WAARDENBURG SYNDROME, TYPE 4A
WAARDENBURG SYNDROME, TYPE IIA
Expand
Broader (2)
Hereditary Diseases
Syndrome
In Blood
Klein's Syndrome
Microbiological
PAX3 wt Allele
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Spectrum of Temporal Bone Abnormalities in Patients with Waardenburg Syndrome and SOX10 Mutations
M. Elmaleh-Bergès
,
C. Baumann
,
+7 authors
V. Pingault
American Journal of Neuroradiology
2013
Corpus ID: 18176431
BACKGROUND AND PURPOSE: Waardenburg syndrome, characterized by deafness and pigmentation abnormalities, is clinically and…
Expand
Highly Cited
2012
Highly Cited
2012
Genome-wide association study of three-dimensional facial morphology identifies a variant in PAX3 associated with nasion position.
L. Paternoster
,
A. Zhurov
,
+9 authors
David M. Evans
American Journal of Human Genetics
2012
Corpus ID: 13925492
Highly Cited
2005
Highly Cited
2005
Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis.
Dong-Seok Kim
,
So-Young Kim
,
+6 authors
Kyoung-Chan Park
Biological and Pharmaceutical Bulletin
2005
Corpus ID: 9080882
In this study, we investigated the effects of 4-n-butylresorcinol on melanogenesis in a spontaneously immortalized mouse…
Expand
Highly Cited
2000
Highly Cited
2000
Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain.
R. Touraine
,
T. Attié-Bitach
,
+14 authors
S. Lyonnet
American Journal of Human Genetics
2000
Corpus ID: 34889842
Waardenburg syndrome type 4 (WS4), also called Shah-Waardenburg syndrome, is a rare neurocristopathy that results from the…
Expand
Highly Cited
1998
Highly Cited
1998
Expression of the SOX10 gene during human development
N. Bondurand
,
A. Kobetz
,
+7 authors
M. Goossens
FEBS Letters
1998
Corpus ID: 13338323
Review
1995
Review
1995
Insight into the microphthalmia gene.
K. J. Moore
Trends in Genetics
1995
Corpus ID: 46106807
Highly Cited
1993
Highly Cited
1993
Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2
M. Tassabehji
,
A. Read
,
+4 authors
T. Strachan
Nature Genetics
1993
Corpus ID: 20767530
Waardenburg syndrome (WS) is a combination of deafness and pigmentary disturbances, normally inherited as an autosomal dominant…
Expand
Highly Cited
1992
Highly Cited
1992
An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome
C. Baldwin
,
C. Hoth
,
J. Amos
,
E. Da‐Silva
,
A. Milunsky
Nature
1992
Corpus ID: 4319436
HERE we report the identification and characterization of a gene defect causing Waardenburg's syndrome with hearing loss in a…
Expand
Review
1977
Review
1977
Heterogeneity in Waardenburg syndrome.
M. J. Hageman
,
J. Delleman
American Journal of Human Genetics
1977
Corpus ID: 29195358
Heterogeneity of Waardenburg syndrome is demonstrated in a review of 1,285 patients from the literature and 34 previously…
Expand
Highly Cited
1971
Highly Cited
1971
Genetic heterogeneity in the Waardenburg syndrome.
S. Arias
Birth defects original article series
1971
Corpus ID: 26742373
Waardenbury syndrome is divided into three groups: Type I, with dystopia; Type II, and "pseudo-Waardenburg" syndrome, without…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE